Results showed that Hes1 expression was significantly (p<0.01) upregulated in CD34+ cells in all six CML samples compared with control (normal CD34+ cells from NBM) group (Fig 3). This evidence concerns the gene HES1 and chronic myelogenous leukemia, BCR-ABL1 positive.